ProPhase Labs Q3 net revenue $24.2M (+155% YoY), net income $1.0M vs loss, adj. EBITDA $6.3M record

ProPhase Labs, Inc.

2022-Q3 EPS reported $1.10 revenue$100,800,000

Q3 2022 net revenue $24.2M, up 155% from $9.5M in Q3 2021; net income $1.0M ($0.06 EPS) vs net loss $4.0M ($0.26 loss).
Adjusted EBITDA $6.3M (record for Q3) versus adjusted EBITDA loss of $1.3M in the prior-year quarter.
Cash, cash equivalents & restricted cash $22.8M at Sep 30, 2022 vs $8.7M at Dec 31, 2021; working capital $53.6M.
Signed MOU with G42 Healthcare for genomic sequencing/AI; entered two-year collaborative agreement with Dana-Farber for Linebacker-1 cancer co-therapy.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

ProPhase Labs, Inc. reported the third quarter ended September 30, 2022 results: revenue $24.2 million, net income $1.0 million, or $0.06 per share, EPS $0.06 per share.

Period: the third quarter ended September 30, 2022
Revenue: $24.2 million
Net income: $1.0 million, or $0.06 per share
EPS: $0.06 per share
Result: reported results

Exact text from the filing

Current Report on Form 8-K. --- EX-99.1 () --- EX-99.1 2 ex99-1.htm Exhibit 99.1 ProPhase Labs Announces Record Third Quarter 2022 Financial Results Q3 2022 Net Revenues of $24.2 Million (a Q3 record); Up 155% Year-over-Year Q3 2022 Net Income of $1.0 Million versus a loss in Q3 2021 Q3 2022 adjusted EBITDA of $6.3 million (a Q3 record) versus a loss in Q3 2021

View on SEC.gov

44 earnings releases filed in the last 30 days. Browse all earnings releases →

ProPhase Labs, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-22-031246

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.